A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Compare the Efficacy and Safety of Denosumab Versus Placebo in Males With Low Bone Mineral Density.
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2015
At a glance
- Drugs Denosumab (Primary)
- Indications Bone resorption; Male osteoporosis
- Focus Registrational; Therapeutic Use
- Acronyms ADAMO
- Sponsors Amgen
- 10 Jun 2017 Biomarkers information updated
- 06 Oct 2013 Results of the transiliac crest bone biopsy substudy (n=29) presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
- 14 Nov 2012 One-year outcomes presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History